Anosmia Clinical Trial
Official title:
Does Cardiopulmonary Bypass Change Olfaction?
The loss of the sense of smell, anosmia, can have profound effects on the lives of those who suffer from it. In our clinical practice, we have encountered several patients complaining of anosmia after recently undergoing surgery requiring cardiopulmonary bypass. We want to investigate this peculiar observation and determine if such a link exists. Thus far, there have been no similar studies published, and as such, no previous evidence on this matter. This study will help formalise and clarify these observations, empowering clinicians to better inform patients in the future; if cardiopulmonary bypass procedures do carry a risk of anosmia. This study may also give rise to further research into the matter.
Objectives: To investigate the incidence of anosmia arising in patients after undergoing
cardiopulmonary bypass, and compare it to a control group.
Hypothesis: Patients undergoing cardiopulmonary bypass may suffer from anosmia.
Methodology: Potential participants will be identified via scheduled operating lists at
Manchester Royal Infirmary. Suitable patients will be informed, including informational
leaflets about the study, and permissions sought with an informed consent form. Once
recruited, when the patients come for their pre-operative assessment, olfactory assessment
will be carried out using the Sniffing Sticks smell kit and a validated questionnaire
(Dresden Questionnaire of Olfactory Disorders). The Sniffing Sticks smell kit composes of 12
different pen-like odour dispensers. Each stick is presented to the patient who then chooses
from four different answers, the one that best represents the odour. The patient then
receives a score of 0 to 12. A reassessment via the same questionnaire and smell kit is
repeated after 1 week or just before discharge (whichever is earlier) after the patient's
surgery.
Data Management and Statistical Analyses: All participant information will be stored
electronically in a password protected trust computer. Participant identifiers will also be
kept in a separate password protected folder from the main database of individual participant
information. We will use MS Excel for compiling the data.
Study Type: Prospective, single-centre, observational study
Target Sample size: 50 patients undergoing elective surgery requiring cardiopulmonary bypass
(study group) 50 patients total
Procedures for Obtaining and Documenting Consent: All patients undergoing major surgery will
require to attend a preoperative planning clinic. Information leaflets will be disseminated
at this time, which includes contact details of involved researchers. Depending on
availability, the principal researcher would be present during the preoperative clinics to
answer any questions. Contact details will be taken for any patient considering to
participate at this point whilst any patient who initially refuse and choose to participate
later will require to contact the researchers to opt back in. Potential participants will
then be contacted via their mode of choice (email/telephone) to assess if they want to
participate. On the day of planned admission into hospital for elective surgery, or at
another agreed upon time, a written consent will be obtained and all questions addressed
immediately before the study is conducted. Patients undergoing major surgery are normally
admitted into hospital the day before surgery. This time period is opportunistic as from
experience, most patients will have ample free time from then till the day of surgery and a
distraction would most probably be welcome. However, if no such opportunity is foreseen, a
separate appointment in hospital grounds can be made at a suitable time. After the operation,
a repeat study will be done, ideally in conjunction with any one of their follow up visits to
the hospital, which normally involves a waiting time. Otherwise, an alternate suitable
appointment can be arranged. Any arranged appointments will restricted to working hours
(Mon-Fri 8am-5pm) in the ENT outpatients department at Manchester Royal Infirmary.
Risks and benefits: There are no risks to patients who participate in this study. There are
also no direct benefits to the participant other than having a free objective measurement of
their sense of smell and learning about the nature of the study. Patient participation is
purely voluntary.
Confidentiality: Each participant will be identified by an assigned code number. This will be
stored in a separate file from the main database, only accessible on a password protected
server. Thus, each participant's data is kept anonymous. Informed consent forms will be
locked a separate file cabinet.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04964414 -
Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19
|
Phase 1/Phase 2 | |
Completed |
NCT05812209 -
Stellate Ganglion Block to Treat Long COVID 19 Case Series
|
||
Completed |
NCT05445921 -
Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction
|
Phase 1/Phase 2 | |
Completed |
NCT04957563 -
Clinical Utility of Olfactory Rehabilitation: Treatment for Pacients With Neurosensorial Anosmia
|
N/A | |
Terminated |
NCT03680911 -
NAC for Head Trauma-induced Anosmia
|
Phase 3 | |
Completed |
NCT04657809 -
Clinical Assessment of Insulin Fast Dissolving Film in Treatment of Post Infection Anosmia
|
Phase 2 | |
Completed |
NCT04853836 -
Olfactory Disfunction and Co-ultraPEALut
|
Phase 4 | |
Recruiting |
NCT05040659 -
Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2
|
||
Recruiting |
NCT05562050 -
Characteristics of the Anosmic Olfactory Mucosa
|
||
Completed |
NCT05152030 -
The Clinical Applicability of the 'TIB' Olfactory Test Device
|
||
Recruiting |
NCT05384561 -
Olfactory Training as a Treatment for Olfactory Dysfunction Post COVID-19
|
N/A | |
Enrolling by invitation |
NCT04764981 -
Olfactory Training for Olfactory Dysfunction After Coronavirus Disease - 19 (COVID-19)
|
N/A | |
Withdrawn |
NCT04408391 -
Brain MRI Imaging in Patients With SARS-Cov2 (COVID-19) Infection With or Without Anosmia
|
||
Completed |
NCT04361474 -
Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity
|
Phase 3 | |
Completed |
NCT03990766 -
Smell Changes & Efficacy of Nasal Theophylline
|
Phase 2 | |
Completed |
NCT04797936 -
BNO 1030 Extract (Imupret) in the Treatment of Mild Forms of COVID-19
|
Phase 4 | |
Recruiting |
NCT04528329 -
Anosmia and / or Ageusia and Early Corticosteroid Use
|
Phase 4 | |
Completed |
NCT04789499 -
Smell in Covid-19 and Efficacy of Nasal Theophylline
|
Phase 2 | |
Recruiting |
NCT04384042 -
Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control Study
|
||
Completed |
NCT04390165 -
Malaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional Study
|